Suggestions

Du même auteur

Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors

Archive ouverte | Largeaud, Laetitia | CCSD

International audience. Describing the prognosis of sub-groups of acute myeloid leukemia (AML) patients treated in real world with current therapies is becoming increasingly relevant to estimate the benefit that new...

Genomic landscape of hyperleukocytic acute myeloid leukemia

Archive ouverte | Largeaud, Laetitia | CCSD

This work has been grant-funded by the CHU de Toulouse (local grant 2018), the Toulouse Cancer Santé Foundation (Toulouse Cancer Health Foundation), the FONROGA Foundation, and the Ligue Contre le Cancer (Anti-Cancer League) Found...

Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study

Archive ouverte | Gadaud, Noémie | CCSD

International audience. We analyzed 526 consecutive acute myeloid leukemia patients refractory to or relapsing after chemotherapy. 270 patients received intensive salvage chemotherapy (IC), 97 azacitidine (AZA) and ...

Chargement des enrichissements...